Assignee
VERNALIS RES LTD
GB·40 granted patents·11 pending applications·578 citations·filing 1998–2009
Top patents by PatentIndex Score
51 records- 0194US7405219B2Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2006·Granted Jul 29, 2008·44 cites·26 claims
- 0293US6706750B1Indole derivatives process for their preparation, pharmaceutical compositions containing them and their medicinal applicationVERNALIS RES LTD·Filed 2000·Granted Mar 16, 2004·68 cites·23 claims
- 0392US6787541B1Thieno-and furopyrimidine derivatives as A2A-receptor antagonistsVERNALIS RES LTD·Filed 2000·Granted Sep 7, 2004·64 cites·40 claims
- 0491US7141575B2Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2002·Granted Nov 28, 2006·45 cites·48 claims
- 0590US7589097B2Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2007·Granted Sep 15, 2009·18 cites·2 claims
- 0687US6828318B22-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmissionVERNALIS RES LTD·Filed 2001·Granted Dec 7, 2004·48 cites·34 claims
- 0782US6583156B14-Quinolinemethanol derivatives as purine receptor antagonists (1)VERNALIS RES LTD·Filed 1999·Granted Jun 24, 2003·33 cites·26 claims
- 0881US7629349B2Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2006·Granted Dec 8, 2009·4 cites·47 claims
- 0981US7253281B2Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indolesVERNALIS RES LTD·Filed 2005·Granted Aug 7, 2007·3 cites·8 claims
- 1080US6608085B14-quinolinemethanol derivatives as purine receptor antagonists (II)VERNALIS RES LTD·Filed 1999·Granted Aug 19, 2003·55 cites·33 claims
- 1177US7384949B2Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2002·Granted Jun 10, 2008·10 cites·30 claims
- 1277US7323473B2Condensed indoline derivatives and their use as 5-HT, in particular 5-HT2C, receptor ligandsVERNALIS RES LTD·Filed 2006·Granted Jan 29, 2008·1 cites·2 claims
- 1377US7323487B2Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2006·Granted Jan 29, 2008·1 cites·2 claims
- 1477US7323486B2Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2006·Granted Jan 29, 2008·1 cites·2 claims
- 1576US7087754B2Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2002·Granted Aug 8, 2006·5 cites·39 claims
- 1676US6962939B1Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2000·Granted Nov 8, 2005·5 cites·14 claims
- 1774US6197788B1(−)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disordersVERNALIS RES LTD·Filed 1998·Granted Mar 6, 2001·42 cites·25 claims
- 1873US6933387B2Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indolesVERNALIS RES LTD·Filed 2003·Granted Aug 23, 2005·4 cites·24 claims
- 1972US7504522B2Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordersVERNALIS RES LTD·Filed 2004·Granted Mar 17, 2009·9 cites·22 claims
- 2072US6433175B1Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonistsVERNALIS RES LTD·Filed 1999·Granted Aug 13, 2002·32 cites·27 claims
- 2168US6800627B1Pirazino indole derivativesVERNALIS RES LTD·Filed 2000·Granted Oct 5, 2004·3 cites·18 claims
- 2268US6380238B1Indoline derivatives as 5-HT2B and or 5-HTC receptor ligandsVERNALIS RES LTD·Filed 1999·Granted Apr 30, 2002·27 cites·23 claims
- 2366US7098333B2Pyrrolo[2,3-d]pyrimidine and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2002·Granted Aug 29, 2006·2 cites·37 claims
- 2466US2008125455A1Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, Receptor ligandsVERNALIS RES LTD·Filed 2007·Application pending·0 cites
- 2566US2008114018A1Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2007·Application pending·0 cites
- 2666US2008090858A1Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2007·Application pending·0 cites
- 2764US7452894B2Purine derivatives as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2002·Granted Nov 18, 2008·2 cites·31 claims
- 2861US7173056B2Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2005·Granted Feb 6, 2007·0 cites·13 claims
- 2961US7166613B2Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligandsVERNALIS RES LTD·Filed 2005·Granted Jan 23, 2007·0 cites·11 claims
- 3061US7166632B2Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsVERNALIS RES LTD·Filed 2005·Granted Jan 23, 2007·0 cites·10 claims
- 3161US6531511B12-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmissionVERNALIS RES LTD·Filed 2000·Granted Mar 11, 2003·2 cites·27 claims
- 3257US6365598B1Pyrroloquinolines for treatment of obesityVERNALIS RES LTD·Filed 1999·Granted Apr 2, 2002·15 cites·29 claims
- 3356US6552062B1Indazole derivatives with 5-HT2 receptor activityVERNALIS RES LTD·Filed 1999·Granted Apr 22, 2003·13 cites·24 claims
- 3456US2008153820A1Thieno(3,2-d)pyrimidines and furano(3,2-d)pyramidines and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2008·Application pending·0 cites
- 3555US7145009B2Pirazino(aza)indole derivativesVERNALIS RES LTD·Filed 2003·Granted Dec 5, 2006·0 cites·14 claims
- 3655US2006160816A1Pirazino(AZA) indole derivativesVERNALIS RES LTD·Filed 2006·Application pending·0 cites
- 3755US2009181939A1Azetidinecarboxamide Derivatives And Their Use In The Treatment Of CB1 Receptor Mediated DisordersVERNALIS RES LTD·Filed 2009·Application pending·0 cites
- 3854US7598256B2Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2006·Granted Oct 6, 2009·0 cites·47 claims
- 3953US2004039200A1Pirazino(AZA)indole derivativesVERNALIS RES LTD·Filed 2003·Application pending·0 cites
- 4051US2006270691A1Purine derivatives as purinergic receptor antagonistsVERNALIS RES LTD·Filed 2006·Application pending·0 cites
- 4149US2007173486A1Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrsVERNALIS RES LTD·Filed 2004·Application pending·0 cites
- 4247US7208494B25HT2c receptor agonistsVERNALIS RES LTD·Filed 2004·Granted Apr 24, 2007·0 cites·21 claims
- 4347US6514961B1Azetidinecarboxamide derivatives for the treatment of CNS disordersVERNALIS RES LTD·Filed 2002·Granted Feb 4, 2003·0 cites·29 claims
- 4447US6403574B1Azetidinecarboxamide derivatives for treating CNS disordersVERNALIS RES LTD·Filed 1999·Granted Jun 11, 2002·7 cites·27 claims
- 4547US2003130354A11-(Adamantyl) amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmissionVERNALIS RES LTD·Filed 2002·Application pending·0 cites
- 4643US7098337B21,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and 1,2,3,4-tetrahydro-2,4a,5-triaza-fluorene derivativesVERNALIS RES LTD·Filed 2003·Granted Aug 29, 2006·0 cites·34 claims
- 4743US6664397B1Use of (+)mefloquine for the treatment of malariaVERNALIS RES LTD·Filed 1998·Granted Dec 16, 2003·8 cites·31 claims
- 4843US2006276452A1Use of azetidinecarboxamide derivatives in therapyVERNALIS RES LTD·Filed 2004·Application pending·0 cites
- 4936US6262106B1Adamantanecarboximidamide derivatives and their use as NMDA antagonistsVERNALIS RES LTD·Filed 1999·Granted Jul 17, 2001·3 cites·15 claims
- 5034US6831078B1Azetidinecarboxamide derivatives for treating CNS disordersVERNALIS RES LTD·Filed 1999·Granted Dec 14, 2004·2 cites·20 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when VERNALIS RES LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →